Tag Archives: neurodegenerative disorders

June, 2018

January, 2018

April, 2017

December, 2016

November, 2016

  • 23 November

    Allergan Expands CNS Portfolio with Acquisition of Chase Pharmaceuticals

    DUBLIN, Nov. 22, 2016 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has completed the acquisition of Chase Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company focused on the development of improved treatments for neurodegenerative disorders including Alzheimer’s disease (AD), Allergan acquired Chase for an …